Aino-Maija Leppä
Hat mitgewirkt an:
-
Characterization of the molecular heterogeneity in acute myeloid leukemia for effective targeting of disease-driving leukemic stem cells
-
Frequent whole blood donations select for DNMT3A variants mediating enhanced response to erythropoietin
-
Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype